Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET
Company Participants
Molly Aggas – Investor Relations, Dalton Agency
A.J. Kazimi – Chief Executive Officer
Todd Anthony – Vice President, Organizational Development
John Hamm – Chief Financial Officer
Conference Call Participants
Operator
Good afternoon. And welcome to Cumberland Pharmaceuticals Third Quarter 2024 Financial Report and Company Update. This call is being recorded at the company’s request and will be archived on its website for one year, from today’s date.
I would now like to turn it over to Molly Aggas, Account Supervisor at the Dalton Agency, who handles Cumberland’s communications. Molly, please proceed.
Molly Aggas
Hello, everyone and thank you for joining us today. Earlier this afternoon, Cumberland issued a press release, announcing the company’s financial results, for the third quarter of 2024 as well as an operational update. The release, which includes the related financial tables, can be found on the company’s website at www.cumberlandpharma.com.
Management will share an overview of those financial results during today’s call. They’ll also provide an overall company update, including a discussion of Cumberland’s brands, pipeline and partners. Participating in today’s call are A.J. Kazimi, Cumberland’s Chief Executive Officer; Todd Anthony, Vice President, Organizational Development; and John Hamm, Chief Financial Officer.
Please keep in mind that their discussions may include some forward-looking statements as defined in the Private Securities Reform Act. Those statements reflect the company’s current views and expectations, concerning future events and may involve risks as well as uncertainties.
d
There are many factors that could affect Cumberlan’s future results, including natural disasters, economic downturns, public health epidemics, international conflicts and others that are beyond the company’s control. Those issues are described under the caption, Risk Factors, in Cumberland’s Form 10-K and any additional updates filed with the SEC. Any forward-looking statements made during today’s
Read the full article here